<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3972">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01306877</url>
  </required_header>
  <id_info>
    <org_study_id>COVHEPH0109</org_study_id>
    <nct_id>NCT01306877</nct_id>
  </id_info>
  <brief_title>Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids</brief_title>
  <acronym>HEMOSTASIS</acronym>
  <official_title>Prospective Single Blinded Randomized Controlled Trial Comparing The Covidien EEA™ Hemorrhoid and Prolapse Stapling Set With DST Series™ Technology Vs. Ethicon PPH03 In A Hemorrhoidopexy Procedure (HEMOSTASIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate that the Covidien EEA™ Hemorrhoid and Prolapse
      Stapling Set for the treatment of hemorrhoids is non-inferior to the competitor device based
      on the primary endpoint.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Intraoperative Bleeding</measure>
    <time_frame>Day 0 - time of surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Number of subjects who require intervention to stop intraoperative bleeding The analysis is based on the per protocol analysis set. Subjects who were misrandomized for excluded from this analysis therefore, the population here will differ from the participant flow.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Operative Pain - (PI-NIRS)</measure>
    <time_frame>Day 0 minus 60 (baseline), Day 0 (discharge), Day 0 plus 7, Day 0 plus 30, Day 0 plus 90, Day 0 plus 180</time_frame>
    <safety_issue>No</safety_issue>
    <description>Post-operative pain as change from baseline pain score as measured by an 11-point Pain Intensity Numeric Rating Scale (PI-NRS). The range of the scale is 0-10 with 0 representing no pain and 10 representing the worst possible pain.
The data represented is the change in baseline score at the different timepoints.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-Operative Pain (Analgesic Intake)</measure>
    <time_frame>Day 0, 1 week, 2 week, 1 month, 3 month, 6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>post operative pain measured in pos-surgical consumption of strong opioids by the number of participants in the study. Participants are included if they consumed analgesics or strong opiod at anytime during the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Quality of Life - General Health Score</measure>
    <time_frame>Day 0 minus 60, 1 week, 1 month, 3 months, 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of life was measured by SF-12 questionnaire in change from baseline; the socring range is 0 - 100 with 0 = poor overall health and 100 = excellent overall health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of the Staple Line</measure>
    <time_frame>Day 0</time_frame>
    <safety_issue>No</safety_issue>
    <description>Distance of staple line to dentate line as measure by surgical ruler</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Day 0 time of discharge minus time of admission</time_frame>
    <safety_issue>No</safety_issue>
    <description>Length of hospital stay is defined as time of anoscope insertion until discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative Room (OR) Time</measure>
    <time_frame>Day 0</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time of insertion of anoscope to time of anoscope removal after stapleline evaluation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">149</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>EEA Hemorrhoid and Prolapse Stapling Set</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Endosurgery Proximate PPH03 Stapling Set</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEA Hemorrhoid and Prolapse Stapling Set</intervention_name>
    <description>Surgical device</description>
    <arm_group_label>EEA Hemorrhoid and Prolapse Stapling Set</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endosurgery Proximate PPH03 Stapling Set</intervention_name>
    <description>Surgical device</description>
    <arm_group_label>Endosurgery Proximate PPH03 Stapling Set</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is able to understand and sign Informed Consent Form

          -  The subject is between 18-85 years of age.

          -  The subject has (symptomatic) Grade 2-3 Hemorrhoids and is eligible for stapled
             hemorrhoidopexy

        Exclusion Criteria:

          -  The procedure is needed as revision hemorrhoid surgery.

          -  Any female patient, who is pregnant, suspected pregnant, or nursing.

          -  The participant has an active or a history of infection requiring antibiotics at the
             intended operative site within thirty (30) days prior to the planned surgery date.

          -  The participant is unable or unwilling to comply with the study requirements,
             follow-up schedule.

          -  The participant has a 1 year history of drug or alcohol abuse.

          -  The participant has a history of venous thrombosis or pulmonary embolism.

          -  The participant has a history of coagulopathy.

          -  The participant has taken aspirin, anti-coagulation and/or anti platelet therapies
             (e.g. Warfarin, Lovenox) within 7 days prior to the planned date of surgery.

          -  The participant has a history of fecal incontinence

          -  The participant has had injection therapy, infrared laser treatment or rubber band
             ligation for treatment of hemorrhoids within 1 month of screening

          -  The participant has co-morbidities which, in the opinion of the investigator, will
             not be appropriate for the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge Marcet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>USF Tampa General Hospital Dept of Surgery</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <lastchanged_date>October 24, 2014</lastchanged_date>
  <firstreceived_date>January 28, 2011</firstreceived_date>
  <firstreceived_results_date>February 20, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hemorrhoid</keyword>
  <keyword>hemorrhoid stapler</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
          <description>EEA Hemorrhoid and Prolapse Stapling Set : Surgical device</description>
        </group>
        <group group_id="P2">
          <title>Endosurgery Proximate PPH03 Stapling Set</title>
          <description>Endosurgery Proximate PPH03 Stapling Set : Surgical device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="78"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="67"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
          <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
        </group>
        <group group_id="B2">
          <title>Endosurgery Proximate PPH03 Stapling Set</title>
          <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="78"/>
                <measurement group_id="B2" value="71"/>
                <measurement group_id="B3" value="149"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="55.4" spread="13.8"/>
                <measurement group_id="B2" value="52.1" spread="13.4"/>
                <measurement group_id="B3" value="53.8" spread="13.7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="39"/>
                <measurement group_id="B2" value="27"/>
                <measurement group_id="B3" value="66"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="39"/>
                <measurement group_id="B2" value="44"/>
                <measurement group_id="B3" value="83"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>American Indian or Alaska Native</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Asian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="5"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Native Hawaiian or Other Pacific Islander</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black or African American</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5"/>
                <measurement group_id="B2" value="7"/>
                <measurement group_id="B3" value="12"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="66"/>
                <measurement group_id="B2" value="58"/>
                <measurement group_id="B3" value="124"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>More than one race</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="4"/>
                <measurement group_id="B3" value="7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Hemorrhoid Grade</title>
          <description>Hemorrhoid grading is based on the scale from The American Society of Colon and Rectal Surgeons classification where grade IV represents the worst onset of hemorrhoids and grade I is the best case. Surgeons use the following classification to grade subjects in the study. Grades increase in severity with Grade I being better than Grade IV Grade Physical Findings I Prominent hemorrhoidal vessels, no prolapse
II Prolapse with Valsalva and spontaneous reduction
III Prolapse with Valsalva requires manual reduction
IV Chronically prolapsed manual reduction ineffective</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Grade 1</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Grade 2</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
                <measurement group_id="B2" value="20"/>
                <measurement group_id="B3" value="48"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Grade 3</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="50"/>
                <measurement group_id="B2" value="51"/>
                <measurement group_id="B3" value="101"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Grade 4</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Smoking History</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Non-Smoker</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="49"/>
                <measurement group_id="B2" value="38"/>
                <measurement group_id="B3" value="87"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Past Smoker</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="12"/>
                <measurement group_id="B2" value="24"/>
                <measurement group_id="B3" value="36"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Current Smoker</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="9"/>
                <measurement group_id="B3" value="26"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Prior Hemorrhoid Treatment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>At least 1 Treatment</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="29"/>
                <measurement group_id="B2" value="36"/>
                <measurement group_id="B3" value="65"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Treatment</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="49"/>
                <measurement group_id="B2" value="35"/>
                <measurement group_id="B3" value="84"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="27.94" spread="17.61"/>
                <measurement group_id="B2" value="27.11" spread="4.85"/>
                <measurement group_id="B3" value="27.54" spread="4.97"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="81.69" spread="17.61"/>
                <measurement group_id="B2" value="81.29" spread="18.65"/>
                <measurement group_id="B3" value="81.50" spread="18.05"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intraoperative Bleeding</title>
        <description>Number of subjects who require intervention to stop intraoperative bleeding The analysis is based on the per protocol analysis set. Subjects who were misrandomized for excluded from this analysis therefore, the population here will differ from the participant flow.</description>
        <time_frame>Day 0 - time of surgery</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="76"/>
                  <measurement group_id="O2" value="68"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Intraoperative Bleeding</title>
            <description>Number of subjects who require intervention to stop intraoperative bleeding The analysis is based on the per protocol analysis set. Subjects who were misrandomized for excluded from this analysis therefore, the population here will differ from the participant flow.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="32"/>
                  <measurement group_id="O2" value="50"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>Yes</non_inferiority>
            <non_inferiority_desc>The objective is to reject H0 at the 0.05 significance level. A one-sided 95% confidence upper limit for PC - PE will be constructed by Newcombe’s generalized Wilson score method (Newcombe 1998). H0 will be rejected at the 0.05 significance level if this upper limit is &lt;7%.</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <p_value_desc>P-value calculated from per protocol analysis set</p_value_desc>
            <method>Chi-squared</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.314</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>-0.18</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Operative Pain - (PI-NIRS)</title>
        <description>Post-operative pain as change from baseline pain score as measured by an 11-point Pain Intensity Numeric Rating Scale (PI-NRS). The range of the scale is 0-10 with 0 representing no pain and 10 representing the worst possible pain.
The data represented is the change in baseline score at the different timepoints.</description>
        <time_frame>Day 0 minus 60 (baseline), Day 0 (discharge), Day 0 plus 7, Day 0 plus 30, Day 0 plus 90, Day 0 plus 180</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="78"/>
                  <measurement group_id="O2" value="71"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Post Operative Pain - (PI-NIRS)</title>
            <description>Post-operative pain as change from baseline pain score as measured by an 11-point Pain Intensity Numeric Rating Scale (PI-NRS). The range of the scale is 0-10 with 0 representing no pain and 10 representing the worst possible pain.
The data represented is the change in baseline score at the different timepoints.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>(Day 0 minus 60) Baseline</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="2.3"/>
                  <measurement group_id="O2" value="2.1" spread="2.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>(Day 0) Discharge</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.0" spread="2.8"/>
                  <measurement group_id="O2" value="0.8" spread="3.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>(Day 0 plus 7) Week 1</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="3.1"/>
                  <measurement group_id="O2" value="0.3" spread="3.2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>(Day 0 plus 30) Month 1</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-1.0" spread="2.5"/>
                  <measurement group_id="O2" value="-1.4" spread="2.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>(Day 0 plus 90) Month 3</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-1.5" spread="2.2"/>
                  <measurement group_id="O2" value="-1.8" spread="2.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>(Day 0 plus 180) Month 6</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-1.5" spread="2.3"/>
                  <measurement group_id="O2" value="-2.0" spread="2.6"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-Operative Pain (Analgesic Intake)</title>
        <description>post operative pain measured in pos-surgical consumption of strong opioids by the number of participants in the study. Participants are included if they consumed analgesics or strong opiod at anytime during the study.</description>
        <time_frame>Day 0, 1 week, 2 week, 1 month, 3 month, 6 month</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="78"/>
                  <measurement group_id="O2" value="71"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Post-Operative Pain (Analgesic Intake)</title>
            <description>post operative pain measured in pos-surgical consumption of strong opioids by the number of participants in the study. Participants are included if they consumed analgesics or strong opiod at anytime during the study.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Surgery - discharge</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="37"/>
                  <measurement group_id="O2" value="25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Discharge - 1 week post op</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="29"/>
                  <measurement group_id="O2" value="18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 week - 2 week post op</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="14"/>
                  <measurement group_id="O2" value="15"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>2 week - 1 month post op</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="5"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 month - 3 month post op</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>3 month - 6 month post op</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Quality of Life - General Health Score</title>
        <description>Quality of life was measured by SF-12 questionnaire in change from baseline; the socring range is 0 - 100 with 0 = poor overall health and 100 = excellent overall health</description>
        <time_frame>Day 0 minus 60, 1 week, 1 month, 3 months, 6 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="70"/>
                  <measurement group_id="O2" value="62"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Overall Quality of Life - General Health Score</title>
            <description>Quality of life was measured by SF-12 questionnaire in change from baseline; the socring range is 0 - 100 with 0 = poor overall health and 100 = excellent overall health</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>baseline</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="53.89" spread="8.31"/>
                  <measurement group_id="O2" value="54.58" spread="8.65"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 week</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="-0.26" spread="6.27"/>
                  <measurement group_id="O2" value="-2.13" spread="5.90"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.44" spread="8.06"/>
                  <measurement group_id="O2" value="-1.05" spread="6.62"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>3 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.88" spread="8.46"/>
                  <measurement group_id="O2" value="-0.05" spread="6.91"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.36" spread="7.93"/>
                  <measurement group_id="O2" value="-0.72" spread="6.46"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Location of the Staple Line</title>
        <description>Distance of staple line to dentate line as measure by surgical ruler</description>
        <time_frame>Day 0</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="78"/>
                  <measurement group_id="O2" value="71"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Location of the Staple Line</title>
            <description>Distance of staple line to dentate line as measure by surgical ruler</description>
            <units>mm</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="25.94" spread="8.23"/>
                  <measurement group_id="O2" value="24.00" spread="8.39"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.1844</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay</title>
        <description>Length of hospital stay is defined as time of anoscope insertion until discharge</description>
        <time_frame>Day 0 time of discharge minus time of admission</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="78"/>
                  <measurement group_id="O2" value="71"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Length of Stay</title>
            <description>Length of hospital stay is defined as time of anoscope insertion until discharge</description>
            <units>Hours</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4.16" spread="6.17"/>
                  <measurement group_id="O2" value="4.37" spread="6.64"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.5647</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Operative Room (OR) Time</title>
        <description>Time of insertion of anoscope to time of anoscope removal after stapleline evaluation</description>
        <time_frame>Day 0</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
            <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
          </group>
          <group group_id="O2">
            <title>Endosurgery Proximate PPH03 Stapling Set</title>
            <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="78"/>
                  <measurement group_id="O2" value="71"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Operative Room (OR) Time</title>
            <description>Time of insertion of anoscope to time of anoscope removal after stapleline evaluation</description>
            <units>minutes</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="25.4" spread="14.5"/>
                  <measurement group_id="O2" value="25.6" spread="13.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>0.9062</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Two years - January 2011 to Jan 2013</time_frame>
      <desc>HEEA N=81 is the total population that was intended to be randomized to the study device using the intent to treat modality. The per protocol population once the misrandomized subjects were excluded is N=78</desc>
      <group_list>
        <group group_id="E1">
          <title>EEA Hemorrhoid and Prolapse Stapling Set</title>
          <description>EEA Hemorrhoid and Prolapse Stapling Set: Surgical device</description>
        </group>
        <group group_id="E2">
          <title>Endosurgery Proximate PPH03 Stapling Set</title>
          <description>Endosurgery Proximate PPH03 Stapling Set: Surgical device</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 13.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="81"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Faecoloma</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Tooth Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 13.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="65" subjects_at_risk="81"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anorectal Discomfort</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="81"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="81"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="81"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" events="21" subjects_affected="19" subjects_at_risk="81"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="68"/>
              </event>
              <event>
                <sub_title>Rectal Hemorrhage</sub_title>
                <counts group_id="E1" events="17" subjects_affected="14" subjects_at_risk="81"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Operative Hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Suture Insertion</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="81"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tam LaFleur, Clinical Project Manager</name_or_title>
      <organization>Covidien</organization>
      <phone>203-821-4744</phone>
      <email>tam.lafleur@covidien.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
